Decide on AstraZeneca’s diabetes drug pleas within 15 days, apex court tells Delhi HC

AstraZeneca holds two patents for Dapagliflozin in India. The first expired on October 2 and the other one is due to expire on May 15, 2023.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...